Tower Research Capital (TRC)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,316
Closed -$3K 6653
2023
Q1
$3K Sell
8,316
-5,176
-38% -$4.64K ﹤0.01% 5296
2022
Q4
$11K Sell
13,492
-196,400
-94% -$261K ﹤0.01% 3932
2022
Q3
$330K Buy
209,892
+134,712
+179% +$306K 0.01% 1468
2022
Q2
$151K Sell
75,180
-48,986
-39% -$84.7K ﹤0.01% 1994
2022
Q1
$289K Buy
124,166
+86,494
+230% +$270K ﹤0.01% 1492
2021
Q4
$175K Sell
37,672
-47,072
-56% -$292K ﹤0.01% 1872
2021
Q3
$647K Buy
84,744
+77,495
+1,069% +$657K 0.02% 805
2021
Q2
$70K Sell
7,249
-42,706
-85% -$340K ﹤0.01% 2741
2021
Q1
$413K Buy
49,955
+42,957
+614% +$454K 0.01% 1396
2020
Q4
$47K Sell
6,998
-269,716
-97% -$2.17M ﹤0.01% 3187
2020
Q3
$3.09M Buy
276,714
+189,302
+217% +$1.73M 0.03% 187
2020
Q2
$549K Buy
+87,412
New +$335K 0.02% 940
2020
Q1
Sell
-97
Closed 4194
2019
Q4
$0 Sell
97
-13,803
-99% -$32.9K ﹤0.01% 4636
2019
Q3
$30K Buy
13,900
+13,612
+4,726% +$31.7K ﹤0.01% 2199
2019
Q2
$1K Buy
288
+188
+188% +$677 ﹤0.01% 3528
2019
Q1
$0 Buy
+100
New +$262 ﹤0.01% 4479
2018
Q4
Sell
-20,749
Closed -$91K 4531
2018
Q3
$91K Buy
+20,749
New +$115K 0.01% 1410
2018
Q2
Sell
-100
Closed -$1K 4218
2018
Q1
$1K Buy
+100
New +$711 ﹤0.01% 3128
2017
Q4
Sell
-2,872
Closed -$5K 4292
2017
Q3
$5K Sell
2,872
-4,724
-62% -$8.67K ﹤0.01% 3345
2017
Q2
$15K Buy
7,596
+6,885
+968% +$13.4K ﹤0.01% 1387
2017
Q1
$3K Sell
711
-184
-21% -$923 ﹤0.01% 2521
2016
Q4
$4K Buy
895
+890
+17,800% +$5.35K ﹤0.01% 3184
2016
Q3
$0 Buy
+5
New +$34 ﹤0.01% 4705
2016
Q2
Sell
-3,485
Closed -$19K 5171
2016
Q1
$19K Buy
3,485
+2,815
+420% +$16.4K ﹤0.01% 1396
2015
Q4
$6K Buy
670
+470
+235% +$3.96K ﹤0.01% 2852
2015
Q3
$2K Sell
200
-2,269
-92% -$36.1K ﹤0.01% 3441
2015
Q2
$44K Buy
2,469
+29
+1% +$373 ﹤0.01% 1475
2015
Q1
$28K Buy
+2,440
New +$28.2K ﹤0.01% 1981
2014
Q4
Sell
-450
Closed -$2K 4901
2014
Q3
$2K Sell
450
-369
-45% -$1.98K ﹤0.01% 3907
2014
Q2
$6K Sell
819
-1,287
-61% -$9.71K ﹤0.01% 2764
2014
Q1
$27K Buy
+2,106
New +$23.3K ﹤0.01% 1617

Other funds holding SRNE